🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The "Big 3" insulin makers drew favorable news coverage for "cutting prices to $25/vial." But a new survey reveals those "cuts" haven't reached most patients. T1International: Most patient advocates "have been unable to get the promised $25 insulin." 🔗: warren.senate.gov/imo/media/doc/…

The large number of recalls these 503b's generate are difficult to manage in hospitals. FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls statnews.com/pharmalot/2023… via STAT

Great to see a nonprofit pharma bringing a critical public health product to market

Day 16: Insurance is still refusing to fill the insulin that keeps me alive. My “options” are: pay $2,267.99 for a 3-month supply of insulin or die. This is why insulin PRICES, not copays, must be capped. Insurance is not the answer to the insulin affordability crisis.

Daily reminder that the insulin I need to survive is still $2,267.99 every 3 months. Insurance is not the answer to unaffordable insulin, as insurance was the reason it took 23 DAYS to fill this RX. W/o insulin, I’d be dead in 2. Insulin should be free.

Ukraine came to the aid of the United States after we were attacked on 9/11 and deployed troops to support the ISAF mission in Afghanistan for almost 14 years

Can’t say we weren’t warned.

It has been a busy few years…

"Generic drugs should be cheap, but insurers are charging thousands of dollars for them" (NB - in place of "insurer" read "PBM," though sometimes they are one and the same.) wsj.com/health/healthc…

"Civica is the only pharma created specifically to address drug shortages. The drugs we deliver are not chosen for return-on-investment. They are chosen by hospitals because they are in shortage or at risk of shortage." Allan Coukell, Civica Rx at U.S. Subcommittee on Health hearing

ICYMI - @mganio_ASHP Allan Coukell Civica Rx ASHP provided great recs on fixing the drug shortages problem during todays hearing energycommerce.house.gov/events/health-…

“Across a selection of these so-called specialty generic drugs, Cigna and CVS’s prices were at least 24 times higher on average than roughly what the medicines’ manufacturers charge, the The Wall Street Journal found.” - Joseph Walker wsj.com/health/healthc…

Do Plan Sponsors Understand How Their PBMs Make Money? My $0.02 on how #PBMs' profit model has evolved—and why a plan sponsor can feel satisfied with PBM transparency while remaining unaware of how its PBM actually earns money. PSGconsults drugch.nl/3EIogQT

Big PBMs say “Drugmakers alone have the power to set prices.” Then how is that the same PBM set five different prices for the same drug, at the same pharmacy, on the same day, where the delta between the bookends had an over 10x difference? Our latest: 3axisadvisors.com/projects/2023/…

"Civica Rx significantly increased supply security and lowered the cost in aggregate...these medications are critical to patient care & have been prone to shortages." - Carter Dredge, SSM Health NEJM Catalyst Civica Rx ssmhealth.com/newsroom/2023/…

Or 300 students at U Mass. Just saying.

.Forbes released its 2023 philanthropy scorecard and once again, John Arnold and Laura Arnold earned the highest score — a rare 5 — for their charitable giving. Only 11 people from the #Forbes400 have given away more than 20% of their wealth: bit.ly/3RGcRsI

Vaccinating Health Care Supply Chains Against Market Failure: The Case of Civica Rx: nej.md/465buYs Civica Rx SSM Health

A spot-on bit for all my fellow nerds out there

🧐 this receipt from CVS, where the insurance is billed $363, and the customer pays $64.45/90 tabs of Atorvastatin. Here, that would be about $1.49 + a fair $5 member fee. For the doubters: a stock bottle that cost us just $11.88/1000ct. We can buy 5,425 tablets for $64.45!!